PureTech Health (PRTC) Assets Average (2021 - 2025)
PureTech Health (PRTC) reported Assets Average of $544.0 million for Q4 2025, down 8.0% year-over-year from $591.3 million in Q4 2024, and down 5.88% quarter-over-quarter from $577.9 million in Q2 2025.
PureTech Health (PRTC) Assets Average (2021 - 2025) Analysis & Trends
PureTech Health (PRTC) has 5 years of Assets Average data on file, last reported at $544.0 million in Q4 2025.
- Assets Average for Q4 2025 came in at $544.0 million, down 8.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $544.0 million (down 8.0% YoY), and the FY2025 annual result was $568.7 million, down 12.28% from the prior year.
- Assets Average declined to $544.0 million in Q4 2025 per PRTC's latest filing, from $577.9 million in the prior quarter.
- Over five years, Assets Average peaked at $968.0 million in Q4 2021 and troughed at $544.0 million in Q4 2025.
- A 5-year average of $691.5 million and a median of $637.0 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average declined 15.33% in 2024, then dropped 8.0% in 2025.
- A 5-year view of Assets Average shows it stood at $968.0 million in 2021, then retreated by 14.84% to $824.3 million in 2022, then fell by 15.29% to $698.3 million in 2023, then decreased by 15.33% to $591.3 million in 2024, then slipped by 8.0% to $544.0 million in 2025.
- Business Quant data shows PRTC's Assets Average at $544.0 million in Q4 2025, $577.9 million in Q2 2025, and $591.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 543.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 543.98 Mn |
| Jun 30, 2025 | 577.94 Mn |
| Dec 31, 2024 | 591.29 Mn |
| Jun 30, 2024 | 636.96 Mn |
| Dec 31, 2023 | 698.31 Mn |
| Dec 31, 2022 | 824.33 Mn |
| Dec 31, 2021 | 968.00 Mn |